|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.180 EGP | -3.28% |
|
-4.84% | +3.51% |
| 17/05 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 20/02 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 1.24 | 1.53 | 1.96 |
| Spread/Res. | -4.84% | -22.88% | -39.80% |
| Spread/Supp. | +0.00% | +11.32% | +13.24% |
| Support | 1.18 | 1.06 | 1.042 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MCRO Stock
- Charts Macro Group Pharmaceuticals (Macro Capital) S.A.E
Select your edition
All financial news and data tailored to specific country editions
